JHS Svendgaard Laboratories Ltd

JHS Sven.Lab. has faced significant financial challenges, with fluctuating net sales and increasing losses, reporting a profit after tax of -19.74 Cr in March 2025 and negative cash flow from operating activities of -5.00 Cr. Total liabilities matched total assets at 197.87 Cr, indicating a difficult financial position.

JHS Sven.Lab. has experienced fluctuating net sales and significant losses, with net sales increasing to 92.00 Cr in March 2025 but operating profit declining to -1.13 Cr and a profit after tax loss of -19.74 Cr. The company faces rising raw material costs and increasing total liabilities, indicating ongoing financial challenges.

JHS Sven.Lab. will announce its results on 14 November 2025.

JHS Sven.Lab. will announce its results on 14 November 2025.

As of 11-Nov, JHS Svendgaard Laboratories Ltd's stock price is 12.05, down 2.11%, and has underperformed its sector and the broader market significantly, with a year-to-date decline of 44.39%. Despite increased investor participation, the stock continues to trend downward, contrasting sharply with the Sensex's gains.

As of 29-Oct, JHS Svendgaard Laboratories Ltd's stock price is 12.60, down 5.33% and has declined 41.86% year-to-date, significantly underperforming the Sensex. Despite a recent monthly gain of 16.67%, the overall trend remains negative with substantial long-term underperformance.

As of 24-Oct, JHS Svendgaard Laboratories Ltd is seeing a price increase to 13.67, up 2.7%, with strong recent performance including an 8-day gain of 24.61%. Despite being down 36.92% year-to-date, increased investor interest and positive short-term returns indicate a potential recovery phase.

As of 17-Oct, JHS Svendgaard Laboratories Ltd's stock price is 12.76, up 2.16% recently, with strong short-term gains but negative long-term performance, declining 41.12% year-to-date. The stock has outperformed the Sensex in the short term, indicating potential recovery despite ongoing challenges.

As of 15-Oct, JHS Svendgaard Laboratories Ltd is seeing a price increase to 11.82, up 7.07% recently, with strong short-term gains but significant long-term losses of 45.45% year-to-date. Despite recent positive momentum, declining delivery volume suggests caution for future price movements.

As of 13-Oct, JHS Svendgaard Laboratories Ltd's stock price is declining at 10.97, down 2.75%, and has significantly underperformed its sector and the benchmark Sensex. The stock has seen substantial declines over various periods, indicating weak investor sentiment and participation.

As of 06-Oct, JHS Svendgaard Laboratories Ltd's stock price is at 11.66, up 4.95%, but it has declined 46.19% year-to-date and 57.71% over the past year. Despite recent short-term gains, the stock's long-term performance remains weak, raising concerns about sustained investor interest.

As of 24-Sep, JHS Svendgaard Laboratories Ltd is currently priced at 11.35, reflecting a 3.65% increase, but has underperformed significantly over the past year, down 63.16%. Despite recent gains, declining investor participation and historical losses raise concerns about future performance.

As of 23-Sep, JHS Svendgaard Laboratories Ltd's stock price is 11.11, down 1.59%, reflecting a trend reversal after recent gains. The stock has significantly underperformed the benchmark Sensex year-to-date, with a return of -48.73% compared to the Sensex's 5.07% gain.

As of 22-Sep, JHS Svendgaard Laboratories Ltd's stock price is at 11.22, reflecting a recent 0.36% increase, but it has significantly underperformed over the past year with a 61.86% decline. The company's weak fundamentals and negative returns indicate it remains a risky investment despite short-term gains.

As of 19-Sep, JHS Svendgaard Laboratories Ltd is seeing a price increase to 11.22, but it remains below key moving averages and has significant long-term challenges, including negative EBITDA and a 63.09% decline over the past year. Despite a short-term gain, the overall outlook is concerning compared to the broader market.

As of 18-Sep, JHS Svendgaard Laboratories Ltd's stock price is 10.64, down 3.45%, with a significant decline of 66.75% over the past year. The company faces weak fundamentals, including negative operating profit growth and challenges in servicing its debt, contributing to a negative outlook despite increased investor participation.

As of 17-Sep, JHS Svendgaard Laboratories Ltd's stock price is declining at 11.02, down 2.3%, with significant underperformance reflected in a -64.02% return over the past year compared to the Sensex's slight decline. The company faces weak fundamentals, including negative profit growth and poor returns on capital, contributing to a bearish market sentiment.

As of 16-Sep, JHS Svendgaard Laboratories Ltd's stock price is at 11.28, showing a slight increase but trading below all moving averages, indicating weak performance. Despite a year-to-date decline of 47.95%, there is increased investor interest with a significant rise in delivery volume.